Compare Halliburton Company (HAL) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halliburton Company vs Hims and Hers Health Inc — how do they compare? Halliburton Company trades at $32.46 (market cap $27.14B), while Hims and Hers Health Inc trades at $29.88 (market cap $6.55B). The key difference: Halliburton Company is far larger — about 4.1× Hims and Hers Health Inc's market cap, and Halliburton Company pays a 2.09% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halliburton Company for 89 Days and Hims and Hers Health Inc for 21 Days on average.
| HAL | HIMS | |
|---|---|---|
Market Cap | $27.14B | $6.55B |
Volume | 11,258,156 | 14,842,814 |
Sector | Energy | Health |
52-Week High | $42.98 | $62.76 |
52-Week Low | $21.82 | $14.52 |
Typical Hold Time | 89 Days | 21 Days |
Enterprise Value | $33.29B | $7.25B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Halliburton (HAL) trades at $32.57, up 2.58% today, with a bearish technical signal despite recent earnings beats. The company shows solid profitability with a 7.16% net income margin and 14.89% ROE, though revenue dipped slightly in 2025. Recent news highlights expansion in Venezuela and a new deepwater contract in Cyprus, signaling growth initiatives. Analyst consensus is strongly bullish with a $43.11 price target, but technical indicators and recent CFO stock sales introduce caution.
The outlook for HAL is mixed; strong analyst support and strategic contracts offer upside, but technical weakness and exposure to oil price volatility pose risks. Investors should weigh the company's solid fundamentals and growth projects against market sentiment and industry cyclicality for balanced decision-making.
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
